(Q43179791)

15 November 2017

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy (English)

1 reference

Francisco Rodríguez-Frías

15 November 2017

1 reference

1 reference

David Tabernero

3

0 references

object named as

Francisco Rodriguez-Frias

2

0 references

Rafael Esteban

object named as

Rafael Esteban

6

0 references

Maria Buti

7

object named as

Maria Buti

1 reference

15 November 2017

Rosendo Jardi

1

1 reference

15 November 2017

Maria Homs

4

1 reference

15 November 2017

Melanie Schaper

5

1 reference

15 November 2017

language of work or name

English

0 references

publication date

3 December 2008

1 reference

Journal of Clinical Microbiology

15 November 2017

1 reference

15 November 2017

47

1 reference

15 November 2017

2

1 reference

15 November 2017

485-488

1 reference

Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Antiviral therapy of chronic hepatitis B.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643676

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19052182

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/JCM.01678-08

1 reference

release_5sb4e7ofyfcqfarpq3zcme3vwa

15 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5sb4e7ofyfcqfarpq3zcme3vwa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 November 2017

PubMed publication ID

19052182

1 reference